{"id":10478,"date":"2016-09-23T10:51:02","date_gmt":"2016-09-23T09:51:02","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=10478"},"modified":"2016-09-23T10:34:13","modified_gmt":"2016-09-23T09:34:13","slug":"medisinsk-forskning-skal-bli-mer-anvendbar","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/nb_no\/2016\/09\/23\/medisinsk-forskning-skal-bli-mer-anvendbar\/","title":{"rendered":"[:no]Medisinsk forskning skal bli mer anvendbar[:en]Medical research should be more applicable[:]"},"content":{"rendered":"<p>[:no]<a href=\"http:\/\/k2info.w.uib.no\/files\/2016\/04\/Narr.jpg\" rel=\"attachment wp-att-9193\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-9193 size-thumbnail\" src=\"http:\/\/k2info.w.uib.no\/files\/2016\/04\/Narr-150x150.jpg\" alt=\"Narr\" width=\"150\" height=\"150\" \/><\/a>Det legges nye f\u00f8ringer for forskningsmidler finansiert b\u00e5de via samarbeidsorganet og Forskningsr\u00e5det. Vitenskapelig kvalitet er fremdeles et viktig kriterium ved vurdering av s\u00f8knadene, men n\u00e5 skal nytte for pasienten og helsetjenesten tillegges like mye vekt. I det siste punktet ligger at en m\u00e5 synliggj\u00f8re behovet og betydningen av ny kunnskap og innovasjonspotensialet p\u00e5 kort og lang sikt. Med andre ord, h\u00f8y kvalitet eller h\u00f8y nytte alene er ikke nok for \u00e5 n\u00e5 fram i konkurransen om midler.<\/p>\n<p>\u00d8nsket om at pasientene selv skal initiere forskning og at forskningsresultater raskt skal kunne implementeres i klinikken er forst\u00e5elig, men et for ensidig fokus p\u00e5 dette kan ha negative sider. S\u00f8kerne vil kanskje styre unna ambisi\u00f8se h\u00f8y-risikoprosjekter som sikter p\u00e5 \u00e5 adressere mer fundamentale problemstillinger p\u00e5 bekostning av \u00ablow-hanging fruits\u00bb som unders\u00f8kelse av om diett A gir litt lavere langtidsblodsukker enn diett B. Langsiktighet er viktig. Det tar lang tid \u00e5 bygge opp gode forskningsmilj\u00f8 og \u00e5 etablere infrastruktur som pasientregistre, utstyrsplattformer og en slagkraftig forskningsgruppe.<\/p>\n<p>Likevel, denne trenden er noe vi m\u00e5 forholde oss til. N\u00e5r vi skriver s\u00f8knader blir det viktig \u00e5 tenke tverrfaglig og tverrinstitusjonelt for \u00e5 angripe en problemstilling fra mange ulike vinkler. Her er brukermedvirkning, regionalt og nasjonalt samarbeid viktige momenter. For \u00e5 hjelpe forskerne styrker vi n\u00e5 forskningsr\u00e5dgivningen p\u00e5 K2 ved at MOFs forskningsr\u00e5dgiver Itana Sloper-Krivokapic vil ha kontortid fire dager i uken p\u00e5 K2 i 8. etasje. I tillegg ansetter vi i h\u00f8st en egen forskningsr\u00e5dgiver. Bergen teknologioverf\u00f8ring (BTO) vil v\u00e6re tilstede p\u00e5 K2 hver annen tirsdag og vil kunne gi r\u00e5d om hvordan skrive innovasjon inn i s\u00f8knader. I tillegg har Samarbeidsorganet etablert et fagsenter for innovasjon som kan hjelpe med \u00e5 implementere forskningsfunn i klinikken.<\/p>\n<p>Alt dette f\u00f8rer forh\u00e5pentlig til nye gode forskningsprosjekter med god finansiering p\u00e5 K2.<\/p>\n<p>Eystein[:en]<a href=\"http:\/\/k2info.w.uib.no\/files\/2016\/04\/Narr.jpg\" rel=\"attachment wp-att-9193\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-9193 size-thumbnail\" src=\"http:\/\/k2info.w.uib.no\/files\/2016\/04\/Narr-150x150.jpg\" alt=\"Narr\" width=\"150\" height=\"150\" \/><\/a>Emphasis new guidelines for research grants funded by both Samarbeidsorganet and The Recearch Council of Norway.\u00a0Scientific quality is still an important criterion in the evaluation of the applications, but now the patent shall benefit and health services added as much weight. The last point\u00a0demonstrate the need and importance of new knowledge and innovation potential in the short and long term. In other words, high quality or high benefit alone is not enough to reach the competition for funds.<\/p>\n<p>The desire for patients to\u00a0initiate research and that research results quickly, will be implemented in the clinic is understandable, but a unilateral focus on this may have negative aspects. Applicants may steer away from ambitious high-risk projects that aim to address the more fundamental issues at the expense of the &laquo;low-hanging fruits&raquo; that investigate whether diet A gives slightly lower long-term blood sugar than diet B. Persistence is important. It takes a long time to build up good Research <span class=\"equivalent\">environments,<\/span> and establishing infrastructure such as patient records, equipment platforms and a powerful Research Group.<\/p>\n<p>Nevertheless, this trend is something we have to deal with. When we write applications it is\u00a0 important to think in an interdisciplinary and inter-institutional way\u00a0to attack a problem from many different angles. Here are user intervention, regional and national cooperatives important points. To help our\u00a0recearchers, we now strengthen the \u00a0Research advice on K2. MOFs research advisor Itane Sloper-Krivokapi\u0107 will have office hours four days a week at K2 on the 8th floor. In addition, we will also employ a researchadvisor this fall.\u00a0. Bergen technology transfer (BTO) will be present at K2 every other Tuesday, and will be able to advise on how to write innovation into applications. In addition, Samarbeidsorganet\u00a0has established a resource center for innovation that can help to implement research findings in the clinic.<\/p>\n<p>All of this will hopefully lead to New excellent research projects With good fundings at K2.<\/p>\n<p>Eystein[:]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[:no]Det legges nye f\u00f8ringer for forskningsmidler finansiert b\u00e5de via samarbeidsorganet og Forskningsr\u00e5det. Vitenskapelig kvalitet er fremdeles et viktig kriterium ved vurdering av s\u00f8knadene, men n\u00e5 skal nytte for pasienten og helsetjenesten tillegges like mye vekt. I det siste punktet ligger&hellip;<\/p>\n<p class=\"more-link-p\"><a class=\"more-link\" href=\"https:\/\/k2info.w.uib.no\/nb_no\/2016\/09\/23\/medisinsk-forskning-skal-bli-mer-anvendbar\/\">Read more &rarr;<\/a><\/p>\n","protected":false},"author":2783,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44,39969],"tags":[],"class_list":["post-10478","post","type-post","status-publish","format-standard","hentry","category-nyheter","category-ukens-leder"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/10478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/users\/2783"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/comments?post=10478"}],"version-history":[{"count":4,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/10478\/revisions"}],"predecessor-version":[{"id":10482,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/10478\/revisions\/10482"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/media?parent=10478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/categories?post=10478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/tags?post=10478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}